The anti-apoptotic BAG3 protein is expressed in lung carcinomas and regulates small cell lung carcinoma (SCLC) tumor growth

Oncotarget

Volumn 5, Issue 16, 2014, Pages 6846-6853

  Chiappetta, Gennaro ^a   Basile, Anna ^b   Barbieri, Antonio ^a   Falco, Antonia ^b   Rosati, Alessandra ^b   Festa, Michelina ^b   Pasquinelli, Rosa ^a   Califano, Daniela ^a   Palma, Giuseppe ^a   Costanzo, Raffaele ^a   Barcaroli, Daniela ^c   Capunzo, Mario ^b   Franco, Renato ^a   Rocco, Gaetano ^a   Pascale, Maria ^b   Turco, Maria Caterina ^b   De Laurenzi, Vincenzo ^b,c   Arra, Claudio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Apoptosis; BAG3; NSCLC; SCLC; Tumor growth

Indexed keywords

ANTINEOPLASTIC AGENT; BAG3 PROTEIN; CHAPERONE; CISPLATIN; HEAT SHOCK PROTEIN 70; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BAG3 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG PARENCHYMA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SMALL CELL LUNG CANCER; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR INVASION; XENOGRAFT; ANIMAL; BIOSYNTHESIS; CELL GROWTH; GENETICS; LUNG NEOPLASMS; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SMALL CELL LUNG CARCINOMA; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CISPLATIN; DOWN-REGULATION; FEMALE; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MICE; MICE, NUDE; SMALL CELL LUNG CARCINOMA;

EID: 84907069899     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2261     Document Type: Article

References (20)

1. Fru¨h M, De Ruysscher D, Popat S, Crino` L, Peters S, Felip E; ESMO Guidelines Working Group. Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013; 24(6):vi99-105.u`
2. Rossi A, Di Maio M, Chiodini P, Rudd RM, Okamoto H, Skarlos DV, Fru¨h M, Qian W, Tamura T, Samantas E, Shibata T, Perrone F, Gallo C, Gridelli C, Martelli O, Lee SM. Carboplatin-or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data. J Clin Oncol. 2012; 30(14):1692-8.
3. Rosati A, Basile A, Falco A, d'Avenia M, Festa M, Graziano V, De Laurenzi V, Arra C, Pascale M, Turco MC. Role of BAG3 protein in leukemia cell survival and response to therapy. Biochim Biophys Acta. 2012; 1826(2):365-9.
4. Rosati A, Graziano V, De Laurenzi V, Pascale M and Turco MC 2011. BAG3: a multifaceted protein that regulates major cell pathways. Cell Death and Disease. 2011; 2(4): e141
5. Ammirante M, Rosati A, Arra C, Basile A, Falco A, Festa M, Pascale M, d'Avenia M, Marzullo L, Belisario MA, De Marco M, Barbieri A, Giudice A, Chiappetta G, Vuttariello E, Monaco M, Bonelli P, Salvatore G, Di Benedetto M, Deshmane SL, Khalili K, Turco MC, Leone A. IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth. Proc Natl Acad Sci U S A. 2010; 107:7497-7502.
6. Rosati A, Bersani S, Tavano F, Dalla Pozza E, De Marco M, Palmieri M, De Laurenzi V, Franco R, Scognamiglio G, Palaia R, Fontana A, di Sebastiano P, Donadelli M, Dando I, Medema JP, Dijk F, Welling L, di Mola FF, Pezzilli R, Turco MC, Scarpa A. Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival. Am J Pathol. 2012; 181(5):1524-9.
7. Basile A, Del Gatto A, Diana D, Di Stasi R, Falco A, Festa M, Rosati A, Barbieri A, Franco R, Arra C, Pedone C, Fattorusso R, Turco MC, D'Andrea LD. Characterization of a designed vascular endothelial growth factor receptor antagonist helical peptide with antiangiogenic activity in vivo. J Med Chem. 2011; 10;54(5):1391-400.
8. Franco R, Scognamiglio G, Salerno V, Sebastiani A, Cennamo G, Ascierto PA, Botti G, Turco MC, Rosati A. Expression of the anti-apoptotic protein BAG3 in human melanomas. J Invest Dermatol. 2012; 132(1):252-4.
9. Festa M, Del Valle L, Khalili K, Franco R, Scognamiglio G, Graziano V, De Laurenzi V, Turco MC, Rosati A. BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy. Am J Pathol. 2011; 178(6):2504-12.
10. Chiappetta G, Basile A, Arra C, Califano D, Pasquinelli R, Barbieri A, De Simone V, Rea D, Giudice A, Pezzullo L, De Laurenzi V, Botti G, Losito S, Conforti D, Turco MC.BAG3 down-modulation reduces anaplastic thyroid tumor growth by enhancing proteasome-mediated degradation of BRAF protein. J Clin Endocrinol Metab. 2012; 97(1):E115-20.
11. Hensing T, Chawla A, Batra R, Salgia R. A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization. Adv Exp Med Biol. 2014; 799:85-117.
12. Arriola E, Cañadas I, Arumi´-Uri´a M, Do´mine M, Lopez-Vilariño JA, Arpi´ O, Salido M, Mene´ndez S, Grande E, Hirsch FR, Serrano S, Bellosillo B, Rojo F, Rovira A, Albanell J. MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines. J. Cancer. 2011; 105(6):814-23.
13. Tretiakova M, Salama AK, Karrison T, Ferguson MK, Husain AN, Vokes EE, Salgia R. MET and phosphorylated MET as potential biomarkers in lung cancer. J Environ Pathol Toxicol Oncol. 2011; 30(4):341-54.
14. Rolle CE, Kanteti R, Surati M, Nandi S, Dhanasingh I, Yala S, Tretiakova M, Arif Q, Hembrough T, Brand TM, Wheeler DL, Husain AN, Vokes EE, Bharti A, Salgia R. Combination MET inhibition and Topoisomerase I inhibition block cell growth of Small Cell Lung Cancer. Mol Cancer Ther. 2014; 13(3):576-84
15. Cañadas I, Rojo F, Taus A, Arpi´ O, Arumi´-Uri´a M, Pijuan L, Mene´ndez S, Zazo S, Do´mine M, Salido M, Mojal S, Garci´a de Herreros A, Rovira A, Albanell J, Arriola E. Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer. Clin Cancer Res. 2014; 15;20(4):938-50
16. Graveel CR, Tolbert D, Vande Woude GF. MET: a critical player in tumorigenesis and therapeutic target. Cold Spring Harb Perspect Biol. 2013; 1;5(7).
17. Falco A, Rosati A, Festa M, Basile A, De Marco M, d'Avenia M, Pascale M, Dal Piaz F, Tavano F, Di Mola FF, di Sebastiano P, Berloco PB, Nudo F, Caraglia M, Febbraro A, Barcaroli D, Scarpa A, Pezzilli R, De Laurenzi V, Turco MC. BAG3 is a novel serum biomarker for pancreatic adenocarcinomas. Am J Gastroenterol. 2013; 108(7):1178-80.
18. Meng X, Kong DH, Li N, Zong ZH, Liu BQ, Du ZX, Guan Y, Cao L, Wang HQ. Knockdown of BAG3 induces epithelial-mesenchymal transition in thyroid cancer cells through ZEB1 activation. Cell Death Dis. 2014; 27;5:e1092.
19. Xiao H, Cheng S, Tong R, Lv Z, Ding C, Du C, Xie H, Zhou L, Wu J, Zheng S. BAG3 regulates epithelial-mesenchymal transition and angiogenesis in human hepatocellular carcinoma. Lab Invest. 2014; 94(3):252-61.
20. Hosmer, D,W;Lemeshow, S.and May, S. Applied survival analysis; Regression modeling of time-to-event data, 2nd ed; Hoboken, NJ: Wiley, 2008.1-66.